BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Molecular Partners AG 

c/o Department of Biochemistry
Winterthurerstrasse 190
Zürich    8057  Switzerland
Phone: 41-44-635-65-00 Fax: 41-44-635-65-07


SEARCH JOBS










 Company News
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO 9/23/2014 7:05:53 AM
Molecular Partners AG Release: Stage 3 Phase 2 Study Of DARPin Abicipar Pegol (Previously MP0112) Supports Progressing To Phase 3 Development Program 7/1/2014 9:36:24 AM
Roche (RHHBY), Molecular Partners AG Ink $1 Billion+ Cancer Pact 12/4/2013 6:32:39 AM
Molecular Partners AG Announces Publication of Results From a Phase I/II Clinical Trial of Its anti-VEGF DARPin MP0112 in Diabetic Macular Edema 1/17/2013 9:52:15 AM
Allergan Inc. (AGN), Molecular Partners AG Ink $1.5 Billion Exclusive Pact 8/21/2012 6:46:43 AM
Molecular Partners AG Strengthens Management Team With the Appointment of Lisa Rojkjaer, MD as Chief Medical Officer 5/31/2012 10:13:52 AM
Molecular Partners AG Comments on Allergan Inc. (AGN)'s Progress in Phase IIa Retinal Disease Trial Using Anti-VEGF DARPin® 4/5/2012 9:14:07 AM
Johnson & Johnson (JNJ)'s Janssen Biotech Inc. and Molecular Partners AG Expand Agreement to Immunological Diseases in Deal Worth $800 Million 12/8/2011 6:55:49 AM
Swiss Biotech IPOs Including Molecular Partners AG May Revive Health-Care Industry Starved of Investment 7/8/2011 8:28:22 AM
Allergan Inc. (AGN) and Molecular Partners AG Enter Exclusive License Agreement for MP0112; Molecular Partners to Receive $45 Million Upfront and up to $375 Million in Milestone Payments 5/4/2011 8:24:47 AM
12